Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2018)
Twist Bioscience (TWST) posted quarterly Gains from Investment Securities of -$79000.0 for Q3 2018, down 495.0% quarter-over-quarter from $20000.0 in Q2 2018.
Twist Bioscience (TWST) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Twist Bioscience (TWST) has reported Gains from Investment Securities for 2 consecutive years, with -$79000.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Gains from Investment Securities changed N/A year-over-year to -$79000.0; the TTM figure through Sep 2018 stood at -$13000.0 (changed N/A YoY), while the FY2023 annual figure was -$5.9 million, changed N/A from the prior year.
- Gains from Investment Securities eased to -$79000.0 in Q3 2018 per TWST's latest filing, from $20000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $48000.0 in Q1 2018 and bottomed at -$79000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Twist Bioscience | 7.18 Bn | 7.02 Bn | 62.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -79,000.00 |
| Sep 30, 2018 | -79,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Jun 30, 2018 | 20,000.00 |
| Mar 31, 2018 | 48,000.00 |
| Mar 31, 2018 | 48,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Dec 31, 2017 | -2,000.00 |